Years ago, I was interviewed by famed KGO Radio talk show host Ronn Owens and was impressed by his asking just the right questions. Interviewing is a subtle skill, and what seemed like casual conversation -- warmth and encouragement spiced up with humor -- was in fact a friendly interrogation. Afterward I felt as if my brain had been vacuumed.
With a new book on stem cells coming out next month, naturally I thought of the Bay Area's legendary journalist, only to find out he was just recovering from surgery for Deep Brain Stimulation (DBS) to ease the symptoms of his Parkinson's disease.
Asked what he was doing in the hospital, Owens replied:
"Just the normal thing, go in and have a couple holes drilled into your head and have some wires put in."
DBS has been called a pace-maker operation for the brain. A battery device the size of a silver dollar is put under the skin near the collarbone, with a wire going up through the neck into the brain; there it will produce mild shocks to counteract the "abnormal nerve signals that cause PD symptoms".
If all goes well, many of the problems of Parkinson's (tremors and shaking) will be considerably reduced, perhaps for 5-7 years. And, conveniently, if something better comes along, the device can be removed.
To me as a non-scientist, it sounded great. If I had Parkinson's, I would definitely investigate it.
But DBS does not solve the problem: it does not slow neurodegeneration -- the breakdown of the nerves.
If you visit the California Institute for Regenerative Medicine (CIRM) website, you will find about two dozen approaches (at a cost of $44 million) attempting to defeat Parkinson's.
This is as it should be. PD afflicts millions of people around the world, an enormous burden to families and nations. We need to try many ways until we can find the cause, and implement the cure.
Remember Thomas Edison and the light bulb? He and numerous scientists went through thousands of substances, looking for a filament that would carry the light inside the bulb. They finally settled on--carbonized bamboo. When that worked, the world changed.
Everything depends on funding. Here is Dr. Jeanne Loring of Scripps Institution, and the Summit for Stem Cell Foundation. Dr. Loring has had CIRM grants in the past, and hopes for another, this one to challenge PD. Here is how she would fight:
"...The idea is simple; we obtain skin cells from patients and turn them into pluripotent stem cells. Then these cells are made into neurons that make dopamine, with the plan to put those neurons back into the brains of patients to replace the cells that have died. Currently, we have a plan to obtain FDA approval for the therapy in two and a half years, and estimate that it will cost $7.3 million reach that goal ...we are hopeful that there will soon be opportunities for us to apply for... CIRM funding."--Dr. Jeanne Loring, personal communication.
Stem cells may help the body produce the dopamine, the natural chemical which makes motion smooth and coordinated.
For instance, Dr. Xianmin Zeng of the Buck Institute received a CIRM grant for "banking transplant-ready dopaminergic neurons..."
If there was a variety of healthy nerve cells ready to go, the right match could be available for someone in need. This would save time searching-- and prevent the body from rejecting the transplant.
Or, stem cells could be used as a disease model: to test new therapies and medications, to find the cause and cure of the disease.
Dr. Xinnan Wang's work at Stanford University begins with skin cells taken from a Parkinson's patient. She then re-programs the patient cells back to an embryonic-like state. She turns these cells into the nerve cells affected by Parkinson's -- and here it gets exciting.
Dr. Wang's idea is this: in a Parkinson's-affected nerve cell, the mitochondria (the power sources of the cell) are damaged. A healthy body is able to sweep away the damaged mitochondria, as with an invisible broom. But if the "broom" is not working right, damaged mitochondria will just stay there, and essentially rot, spreading poison through the cell. When the nerve cells become intoxicated, the body can't control itself, and the tremors and shakes begin.
"But if you could fix the broom, the body might get rid of the poisons in the nerve cell -- and maybe cure Parkinson's." -- Xinnan Wang, personal communication.
Do you see why scientists all across the world are excited about the California stem cell program? Here, thanks to the vision of the California voters, it is possible to take the risk of making a mistake -- to try new ways -- to challenge incurable disease.
Edison needed thousands of tries to get the light bulb right; what if he had only had the money to try five or six? The world might still be groping in the dark.
If we want to save lives and ease suffering, we might consider California's example, and make funding available to pay for the research. If every state had a department of regenerative medicine, imagine the progress we might make!
And Ronn Owens? He is recovering nicely. I am sure you will join me and the San Francisco Bay Area in wishing him a speedy and full recovery.
Don C. Reed is the author of the forthcoming book, "STEM CELL BATTLES: Proposition 71 and Beyond: How Ordinary People Can Fight Back Against the Crushing Burden of Chronic Disease", available for pre-order now at Amazon.com.
Read the original here:
Parkinson's vs. The California Stem Cell Agency: Disease-a ...
- Stem Cell Therapy for Treatment of Ocular Disorders - Hindawi - December 27th, 2022
- Researchers find out why some stress is good for you - November 6th, 2022
- Shinya Yamanaka - Wikipedia - October 29th, 2022
- Implanting a Patient's Own Reprogrammed Stem Cells Shows Early Positive ... - October 29th, 2022
- World's first stem cell treatment for spina bifida delivered during fetal surgery - UC Davis Health - October 13th, 2022
- JDRF Announces the Appointment of Qizhi Tang, Ph.D., as Co-Director of The JDRF Center of Excellence in Northern California - PR Newswire - October 13th, 2022
- California court creates regulatory uncertainty over the FDA regulation of stem cell therapies - BioEdge - October 4th, 2022
- Scientists have created a mechanical womb that can grow life in the lab - Inverse - October 4th, 2022
- ISCT: California stem cell ruling is flawed and has inserted regulatory uncertainty into the CGT market - BioPharma-Reporter.com - September 16th, 2022
- Scientists Use Stem Cells to Create Synthetic Mouse Embryos - September 16th, 2022
- UK Equine Research Hall of Fame Inductees Announced - Equi Management - September 16th, 2022
- Cultured meat startup Prolific Machines unveils its Henry Ford approach to cell growth - TechCrunch - September 16th, 2022
- New Stem Cell Therapy Protects Brain Against the Neurological Disorder - Nature World News - September 8th, 2022
- Scientists Are Working on New and Improved Hair Loss Treatments - Gizmodo - September 8th, 2022
- What happens to the brain on prescription steroids? - Medical News Today - September 8th, 2022
- How this scientist uses Legos to explain the power of stem cells - August 30th, 2022
- CIRM Bridges intern researches stem cells to grow kidneys - August 30th, 2022
- Alzheimer's: Could controlling the brain's own clean-up crew help? - Medical News Today - August 22nd, 2022
- Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers - Curetoday.com - August 5th, 2022
- Medpoint Global was awarded the Best Revolutionary Hair Transplant Center of the Year and continues to follow developments in its field and offer more... - August 5th, 2022
- Cell Culture Media Market Worth $14.64 Billion by 2029 - Exclusive Report by Meticulous Research - GlobeNewswire - August 5th, 2022
- Haifan Lin takes on new role as President of the ISSCR - EurekAlert - July 3rd, 2022
- UCI-led team discovers signaling molecule that potently stimulates hair growth - UCI News - July 3rd, 2022
- Calidi Biotherapeutics Announces Appointment of W.K. Alfred Yung, M.D., to its Medical Advisory Board - Business Wire - July 3rd, 2022
- Organoids reveal similarities between myotonic dystrophy type 1 and Rett syndrome - EurekAlert - July 3rd, 2022
- Our View: Roe reversal hard hit to science - The Durango Herald - July 3rd, 2022
- Connection Map Reveals Changes in the Injured Brain - Technology Networks - June 22nd, 2022
- Scientists Used CRISPR to Trace Every Human Gene to Its Function - Singularity Hub - June 22nd, 2022
- Maike Sander named to lead the Max Delbrck Center - EurekAlert - June 22nd, 2022
- CRISPR-Cas12a Editing Rates Improve with Better Directions to the Nucleus - Genetic Engineering & Biotechnology News - June 22nd, 2022
- UB-led study presents critical step forward in understanding Parkinson's disease and how to treat it - University at Buffalo - June 13th, 2022
- Stem Cells: A Case for the Use of Human Embryos in Scientific Research - June 4th, 2022
- Top Beverly Hills Plastic Surgeon, Dr. John Anastasatos, Explores Cell-Assisted Lipotransfer (CAL) with Breast Augmentation in New Publication -... - June 4th, 2022
- Regenerative Medicine Market To Grow At A CAGR Of 11.27% By 2027, Due To Advancements In Cell Biology, Genomics Research, And Gene-Editing Technology... - June 4th, 2022
- Google Reverses Ban on Ads for All Stem Cell Therapies, Will Allow FDA-Approved Ones - Gizmodo Australia - May 15th, 2022
- Head-To-Head Survey: Jasper Therapeutics (NASDAQ:JSPR) & CytRx (OTCMKTS:CYTR) - Defense World - May 15th, 2022
- Primary Cell Culture Market Mechanical Separation Segment Is Expected To Witness A Lucrative CAGR Of 11.7% Till 2028, Owing To Advancements In... - May 15th, 2022
- Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM) - BioSpace - May 2nd, 2022
- Predicting the Future of Food - Bon Appetit - May 2nd, 2022
- FDA Grants Direct Biologics Regenerative Medicine Advanced Therapy (RMAT) Designation for the use of ExoFlo in COVID-19 Related ARDS USA - English -... - April 19th, 2022
- Chronic Diseases Is Expected To Have Positive Impact On Stem Cell Characterization Kits Market Demand Bloomingprairieonline - Bloomingprairieonline - April 19th, 2022
- Cleveland Cord Blood Center and Deverra Therapeutics Announce Agreement - Yahoo Finance - April 6th, 2022
- A model that mimics malformation associated with severe epilepsy paves way to novel therapies - EurekAlert - March 25th, 2022
- Stem cell agency: Following the money - and its performance - Capitol Weekly - December 24th, 2021
- Epithelial Cell Culture Media Market to hit US$ 303040.33 thousand by 2028, at 11.4% CAGR: The Insight Partners - Digital Journal - December 24th, 2021
- What is Biohacking? Understanding the Silicon Valley Wellness Trend Youll Hear About in 2022 - SheKnows - December 24th, 2021
- Second Woman Spontaneously Clears HIV: 'We Think More Are Out - Medscape - November 22nd, 2021
- Business Partnership for Development and Commercialization of Medical Device Implant Utilizing MSC2 for the Regeneration of Esophageal Tissue in... - November 22nd, 2021
- Misinformation on stem cell treatments for COVID-19 linked to overhyped science, researchers argue - EurekAlert - October 16th, 2021
- Phase 2 Clinical Trial Data of NurOwn in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in... - October 16th, 2021
- StemExpress Partners with the Alliance for Regenerative Medicine to Provide COVID-19 Testing for the Cell and Gene Meeting on the Mesa - WSAW - October 5th, 2021
- BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa - WWNY - October 5th, 2021
- UC Davis and the School of Medicine set new records in research funding - UC Davis Health - August 31st, 2021
- FDA gives speedy review to Bayer's Parkinson's stem cell therapy - - pharmaphorum - July 21st, 2021
- Stem cell model reveals how COVID-19 can infect the brain - Study Finds - July 21st, 2021
- Introducing the 3D bioprinted neural tissues with the potential to 'cure' human paralysis - 3D Printing Industry - July 21st, 2021
- Insception Lifebank and Cells for Life Join the Generate Life Sciences Family to Create a Global Platform - Canada NewsWire - June 6th, 2021
- Innovative Regenerative Medicine Therapies Safety Comes First - FDA.gov - June 6th, 2021
- ViaCyte to Present Late-Breaking Data at the American Diabetes Association's 81st Scientific Sessions - PRNewswire - June 6th, 2021
- Viral vector unlikely to be cause of leukemia in gene therapy patient - Science Magazine - March 11th, 2021
- Astrocytes Derived from Patients with Bipolar Disorder Malfunction - UC San Diego Health - March 11th, 2021
- Peer Recognition | The UCSB Current - The UCSB Current - March 11th, 2021
- Stem cells on the ballot - Science Magazine - January 20th, 2021
- Controlling the immune system with 'invisible stem' cells - BioNews - January 20th, 2021
- How a UCSF team is giving Cronutt the sea lion a second chance with neuroscience - University of California - October 20th, 2020
- What Proposition 14 Tells Us About California - The New York Times - October 20th, 2020
- California Proposition 14: Funding medical research that uses stem cells - KTLA - October 20th, 2020
- Technology to natures rescue - The Hindu - October 20th, 2020
- What You Need to Know About Prop 14, The Stem Cell Research Bond (Transcript) - KQED - October 5th, 2020
- UC Davis Engineers Lead $36M Effort to Improve Recovery From Spinal Cord Injuries - UC Davis - October 5th, 2020
- Dust off the crystal ball: It's time for STAT's 2020 Nobel Prize predictions - STAT - October 5th, 2020
- Stem Cells Offer Hope of Treatment for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS) - HospiMedica - September 15th, 2020
- David Shavelle, MD, Named Medical Director of Adult Cardiology for the MemorialCare Heart & Vascular Institute at Long Beach Medical Center -... - September 15th, 2020
- Seeing the eye like never before | Newsroom - UW Medicine Newsroom - September 15th, 2020
- Why The FDA's Recent Approval Of New Vaccine Is A Gigantic Win In The War On Cancer - Innovation & Tech Today - September 7th, 2020
- Gore partners with San Diego company on cell delivery system with potential to treat Type 1 diabetes - delawarebusinessnow.com - August 12th, 2020
- Celularity announces the activation of first California Clinical Trial Site following CIRM Grant Award to Advance Treatments for COVID-19 - PRNewswire - August 12th, 2020
- Meet The 12 Next-Gen Food Techs Transforming The Future Of Protein - Green Queen Media - August 12th, 2020
- BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients Suffering from CIN in the US - BioSpace - August 12th, 2020
- BCLI: Phase 3 ALS Data Expected by the End of November 2020 - Yahoo Finance - August 12th, 2020